Celldex Therapeutics, Inc. (CLDX) stock
CLDXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$28.04−0.55 (-1.92%)
Close on Nov 17, 2026Market cap $2.20BP/E –Yield –
Celldex Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Celldex Therapeutics's market cap was $2.37B on Nov 11, 2026, against $1.80B a year earlier. Over the last 5 years it ranged from $1.10B to $3.11B, with a median of $1.72B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.37B | +31.1% |
| 2025 | Dec 31, 2025 | $1.80B | +7.6% |
| 2024 | Dec 31, 2024 | $1.68B | -10.6% |
| 2023 | Dec 29, 2023 | $1.87B | -10.7% |
| 2022 | Dec 30, 2022 | $2.10B | +16.4% |
| 2021 | Dec 31, 2021 | $1.80B | +160.1% |
| 2020 | Dec 31, 2020 | $693.13M | +1854.3% |
| 2019 | Dec 31, 2019 | $35.47M | +5.2% |
| 2018 | Dec 31, 2018 | $33.72M | -91.0% |
| 2017 | Dec 29, 2017 | $375.17M | +4.7% |
| 2016 | Dec 30, 2016 | $358.40M | -76.8% |
| 2015 | Dec 31, 2015 | $1.55B | -5.2% |
| 2014 | Dec 31, 2014 | $1.63B | -16.9% |
| 2013 | Dec 31, 2013 | $1.96B | +381.3% |
| 2012 | Dec 31, 2012 | $408.02M | +255.5% |
| 2011 | Dec 30, 2011 | $114.78M | +40.5% |
| 2010 | Dec 31, 2010 | $81.67M | – |
See a number that looks wrong?